Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

3.12
Delayed Data
As of Feb 23
 +0.01 / +0.32%
Today’s Change
2.88
Today|||52-Week Range
5.18
-20.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization97.0K106.0K87.0K77.0K
 
 
 
 
 
 
Operating ExpensesGross Income-97.0K-106.0K-87.0K-77.0K
 
 
 
 
 
General Expenses4.9M7.3M8.4M5.0M
 
 
 
 
 
Research And Development2.9M4.8M4.9M2.3M
 
 
 
 
 
Total Operating Expenses5.0M7.4M8.5M5.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.0M-7.4M-8.5M-5.1M
 
 
 
 
 
Other Expenses0.00-1.8M0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.9M-9.2M-8.5M-5.0M
 
 
 
 
 
Income Taxes-25.0K0.000.000.00
 
 
Net Income-4.9M-9.2M-8.5M-5.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.7M13.7M18.4M18.7M
 
 
 
 
 
Shares To Calculate EPS Diluted10.7M13.7M18.4M18.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.45-$0.68-$0.46-$0.27
 
 
 
 
 
EPS Diluted-$0.45-$0.68-$0.46-$0.27